"Designing Growth Strategies is in our DNA"

Hospice Care Market Size, Share & Industry Analysis, By Care Model (Routine or Standard Hospice Care, Continuous or Crisis Hospice Care, General Inpatient Hospice Care, Inpatient Respite Care, and Others), By Care Settings (Home-based Hospice Care, Dedicated Hospice Facilities, Hospitals, and Others), By Indication (Cancer, Dementia and Alzheimer's Disease, Cardiovascular Diseases, Chronic Respiratory Diseases, Neurological Diseases, and Others), By Age Group (Adult and Pediatric), and Regional Forecast, 2026-2034

Last Updated: September 30, 2026 | Format: PDF | Report ID: FBI119279

 

Hospice Care Market Size and Future Outlook

Play Audio Listen to Audio Version

The global hospice care market size was valued at USD 44.38 billion in 2025. The market is projected to grow from USD 47.25 billion in 2026 to USD 82.71 billion by 2034, exhibiting a CAGR of 7.3% during the forecast period.

Hospice care refers to a coordinated, interdisciplinary model of end-of-life care that focuses on comfort, symptom management, and quality of life for patients with a terminal prognosis, rather than curative treatment. Services are delivered across a range of settings, including the patient's home, dedicated hospice facilities, and hospitals, and combine nursing care, physician oversight, counseling, spiritual support, and caregiver assistance. The market is growing as aging populations, rising rates of cancer, dementia, and chronic cardiovascular and respiratory disease, and a strengthening policy and reimbursement environment push more patients into structured end-of-life care pathways. The market growth is also supported by increasing patient and family preference for home-based care, expanding hospice bed and program capacity, and continued investment from both non-profit and for-profit providers.

  • In August 2026, Woodlands Hospice expanded Singapore's palliative care capacity by opening a new inpatient facility with 16 beds, with plans to increase capacity to 70 beds to meet growing regional demand.

Furthermore, Gentiva, VITAS Healthcare Corporation, Optum, Inc., Chapters Health System, Inc., and AccentCare, Inc. held the largest market share, driven by increasing investments and planned initiatives, such as facility expansions, partnerships, and acquisitions.

Integration of Telehealth and Remote Patient Monitoring is an Emerging Trend Observed in the Market

A clear market trend is the shift from stand-alone home visits toward technology-enabled hospice care models. Providers increasingly want tools that support remote symptom tracking, virtual physician check-ins, and caregiver communication alongside in-person nursing visits, rather than relying on visit-based care alone. This is particularly visible in North America and parts of Europe, where hospice operators are layering telehealth, remote patient monitoring, and electronic health record integration onto their existing interdisciplinary teams to extend clinical oversight between visits and respond faster to changes in patient condition.

  • In April 2026, Confluence Health launched Epic-based Dorothy Home Care and Comfort Hospice, integrating home-based care with EHR systems to enhance patient information access, care coordination, and continuity.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Growing Burden of Chronic and Terminal Illness Among an Aging Population to Drive Market Growth

One of the strongest global hospice care market growth drivers is the steady increase in the global population aged 65 and above, combined with a persistent and rising burden of cancer, dementia, and chronic cardiovascular and respiratory disease. Hospice care has become deeply embedded in end-of-life practice as it allows interdisciplinary teams to manage pain, symptoms, and psychosocial needs while avoiding the burden of repeated hospitalizations for patients with a limited prognosis. As health systems worldwide face growing pressure from an aging patient base, providers and payers are investing more heavily in structured hospice pathways that improve quality of life and reduce avoidable acute care utilization.

Market Drivers - Impact & CAGR Contribution (2026–2034)

Rank Market Driver Overall Impact CAGR Contribution, 2026–2034 Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Ageing population and rising number of patients with life-limiting chronic diseases High 2.5% High High High
2 Increasing hospice utilization, awareness, and preference for home/community-based end-of-life care High 2.1% High High High
3 Expansion of government reimbursement, insurance coverage, and hospice funding High 1.8% High High Medium
4 Expansion of hospice provider networks, service capacity, and geographic accessibility Medium 1.5% Medium High High
5 Growing adoption of telehospice, digital care coordination, and remote patient-management solutions Medium 1.1% Medium Medium High
6 Others Low 0.9% Low Low Low
Total Positive Growth Contribution 9.90%  

Source: Fortune Business Insights

MARKET RESTRAINTS

Workforce Shortages and Staffing Constraints to Restrict Market Growth

A major restraint for this market is the ongoing shortage of qualified hospice nurses, physicians, social workers, and chaplains. Growing patient volumes are placing sustained pressure on existing workforce capacity, and recruitment and retention challenges are increasing operational costs for providers, particularly in rural and underserved regions. In several markets, hospice agencies have reported declining admissions specifically due to staffing constraints rather than a lack of patient demand, which can slow purchasing decisions around new programs and delay geographic expansion.

Market Restraints - Impact & Negative CAGR Contribution (2026–2034)

Rank Market Restraints Overall Impact CAGR Contribution, 2026–2034 Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Shortage of skilled hospice workforce and rising labor costs High -1.2% High High Medium
2 Stringent reimbursement, eligibility, quality-reporting, audit, and compliance requirements High -0.8% High High Medium
3 Uneven hospice accessibility, low awareness, and late referrals, particularly in underserved markets Medium -0.63% High Medium Medium
4 Others Low -0.2% Low Low Low
Total Negative Restraint Contribution -2.83%  

Source: Fortune Business Insights

MARKET OPPORTUNITIES

Rising Private-Equity Investment and Consolidation Activity to Offer Significant Market Opportunities

The market offers significant opportunities as private equity firms and larger healthcare organizations continue to invest in hospice care, drawn by favorable demographic trends and recurring, government-supported demand. Mergers and acquisitions are giving operators a way to expand geographic reach, improve operational efficiency, and strengthen their position across home-based, facility-based, and general inpatient hospice care.

  • In May 2026, Kinderhook Industries acquired Enhabit, Inc., a home health and hospice provider, in a transaction valued at approximately USD 1.1 billion, underscoring continued investor confidence in the sector.

MARKET CHALLENGES

Complex and Evolving Reimbursement Landscape to Challenge Market Growth

Despite its clinical value, hospice care still faces real-world challenges that can limit adoption and scale-up. Programs depend on close coordination between clinicians, families, and payers, and outcomes can vary between high-volume, well-established providers and smaller or newer agencies. Providers need trained interdisciplinary teams, community relationships, and referral pipelines from hospitals and physicians, all of which create a meaningful entry barrier for smaller operators, particularly in rural and underserved regions.

Segmentation Analysis

By Care Model

Routine or Standard Hospice Care Segment Dominated the Market Owing to Cost-Effectiveness and Broad Patient Eligibility

Based on the care model, the market is divided into routine or standard hospice care, continuous or crisis hospice care, general inpatient hospice care, inpatient respite care, and others.

The routine or standard hospice care segment accounted for the largest share of the global market in 2025. Routine hospice care is the most widely utilized care model as it enables patients with terminal illnesses to receive comprehensive palliative services in their preferred care setting while maintaining comfort and quality of life. The model offers coordinated physician oversight, nursing care, pain and symptom management, counseling, and caregiver support at a relatively lower cost than continuous home care or inpatient hospice services. Additionally, favorable reimbursement policies across developed countries and the growing preference for home-based end-of-life care continue to support the segment's dominant market position.

The continuous or crisis hospice care segment is anticipated to grow with a CAGR of 8.4% over the forecast period. 

To know how our report can help streamline your business, Speak to Analyst

By Care Settings

Home-Based Hospice Care Segment Held the Leading Share Due to Growing Preference for Receiving End-of-Life Care at Home

Based on care settings, the market is segmented into home-based hospice care, dedicated hospice facilities, hospitals, and others.

In 2025, the home-based hospice care segment dominated the global market. The increasing preference among patients and families to receive end-of-life care in familiar surroundings, coupled with improved quality of life and emotional well-being, has significantly driven demand for home hospice services. Home-based care also reduces unnecessary hospital admissions and healthcare expenditures while enabling personalized care through multidisciplinary teams. Furthermore, expanding reimbursement coverage, advancements in remote patient monitoring, and increasing caregiver support programs are accelerating the adoption of home-based hospice services worldwide.

The dedicated hospice facilities segment is anticipated to grow with a CAGR of 8.1% over the forecast period. 

By Indication

Cancer Segment Accounted for the Dominating Share Owing to High Palliative Care Demand

Based on indication, the market is segmented into cancer, dementia and Alzheimer's disease, cardiovascular diseases, chronic respiratory diseases, neurological diseases, and others.

The cancer segment held the leading share of the global market in 2025. Cancer remains one of the leading causes of mortality worldwide, creating a substantial demand for hospice services focused on pain management, symptom control, and psychosocial support during advanced stages of the disease. Patients with terminal cancer frequently require multidisciplinary palliative care to improve comfort and quality of life. Additionally, growing cancer incidence, increasing awareness regarding early integration of palliative care, and supportive reimbursement frameworks continue to strengthen the segment's market leadership.

The dementia and Alzheimer's disease segment is anticipated to grow with a CAGR of 8.5% over the forecast period.

By Age Group

Adult Segment Dominated the Market Due to High Burden of Chronic and Terminal Illnesses

Based on age group, the market is segmented into adult and pediatric.

In 2025, the adult segment held the leading hospice care market share. Adults, particularly the elderly population, represent the majority of hospice care recipients owing to the high prevalence of chronic, life-limiting conditions such as cancer, cardiovascular diseases, chronic respiratory disorders, and neurodegenerative diseases. Increasing global life expectancy, the rising aging population, and greater acceptance of hospice and palliative care services have further contributed to the segment’s growth. Moreover, established clinical guidelines and reimbursement policies for adult hospice care continue to support its widespread adoption across healthcare systems.

The pediatric segment is anticipated to grow at a CAGR of 7.2% over the forecast period.

Hospice Care Market Regional Outlook

By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America Hospice Care Market Size, 2025 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valued at USD 26.39 billion, and also maintained the leading share in 2025, with USD 27.85 billion. The region’s market is expected to increase due to an aged population, established hospice infrastructure, and broad Medicare and private insurance coverage for end-of-life care.

U.S. Hospice Care Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 27.49 billion in 2026, accounting for roughly 58.2% of global sales.

Europe

Europe is projected to record a growth rate of 7.1% in the coming years and reach a valuation of USD 9.89 billion by 2026. The region is estimated to witness considerable market growth due to a well-established palliative care ecosystem, rising life expectancy, and continued integration of hospice into statutory health insurance across major markets.

U.K. Hospice Care Market

The U.K. market size in 2026 is estimated at around USD 2.36 billion, representing roughly 5.0% of global revenues.

Germany Hospice Care Market

Germany’s market value is projected to reach approximately USD 1.98 billion by 2026, equivalent to around 4.2% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 5.91 billion in 2026, securing a significant position in the market. Substantially increasing chronic diseases and rising government support are boosting the region’s market growth.

Japan Hospice Care Market

The Japan market size in 2026 is estimated at around USD 1.62 billion, accounting for roughly 3.4% of global revenues.

China Hospice Care Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 1.90 billion, representing roughly 4.0% of global sales.

India Hospice Care Market

The Indian market size in 2026 is estimated at around USD 0.85 billion, accounting for roughly 1.8% of global revenues.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 1.21 billion by 2026, driven by expanding home-based palliative services and improving healthcare access. Meanwhile, the Middle East & Africa region’s growth is supported by healthcare infrastructure development and rising palliative-care awareness. In the Middle East & Africa region, the GCC market is set to reach a value of USD 0.34 billion by 2026.

South Africa Hospice Care Market

The South Africa market size is projected to reach around USD 0.22 billion by 2026, representing roughly 0.5% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Continued Facility Expansion and Consolidation to Drive Stronger Market Positioning of Leading Players

The global hospice care market has a semi-consolidated competitive structure, comprising prominent players such as Gentiva, VITAS Healthcare Corporation, Optum, Inc., Chapters Health System, Inc., and AccentCare, Inc. These companies hold significant market positions due to their comprehensive portfolio, established global distribution networks, long-standing partnerships, research institutions, and continued investment in technologically advanced care.

  • In March 2026, VITAS Healthcare expanded its hospice service network by opening a new inpatient hospice facility in Florida to strengthen high-acuity end-of-life care and improve patient access.

Other notable players in the global market include Compassus, BrightSpring Health Services Corporation, Bristol Hospice, LLC, The Pennant Group, Inc., and Addus HomeCare Corporation. These companies are expected to prioritize collaborations to increase their global market share during the forecast period.

LIST OF KEY HOSPICE CARE COMPANIES PROFILED

KEY INDUSTRY DEVELOPMENTS

  • July 2026: LiveWell Partners acquired Michigan Community VNA Home Health and Hospice, strengthening its home-based hospice and palliative care presence across the Michigan market.
  • July 2026: Frazier Healthcare Partners agreed to acquire MatrixCare from ResMed, enhancing digital health and electronic health record capabilities supporting hospice and post-acute care providers.
  • May 2026: General Atlantic acquired TEAM Services Group from Alpine Investors, reflecting continued private equity investment and consolidation within the home health and hospice services market.
  • May 2026: The Pennant Group acquired selected hospice and home health locations across Tennessee, Alabama, and Georgia, expanding its post-acute and hospice care footprint in the U.S.
  • February 2025: Kindred Healthcare expanded its integrated home-based and hospice care services to improve care transitions from hospitals to hospice settings and strengthen coordinated end-of-life care delivery.

REPORT COVERAGE

The global hospice care market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a deep competitive landscape with information on the market share and profiles of key operating players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 7.3% from 2026-2034
Unit Value (USD Billion)
Segmentation By Care Model, Care Settings, Indication, Age Group, and Region
By Care Model
  • Routine or Standard Hospice Care
  • Continuous or Crisis Hospice Care
  • General Inpatient Hospice Care
  • Inpatient Respite Care
  • Others 
By Care Settings 
  • Home-based Hospice Care
  • Dedicated Hospice Facilities
  • Hospitals
  • Others
By Indication 
  • Cancer
  • Dementia and Alzheimer's Disease
  • Cardiovascular Diseases
  • Chronic Respiratory Diseases
  • Neurological Diseases
  • Others
By Age Group 
  • Adult
  • Pediatric
By Region 
  • North America (By Care Model, Care Settings, Indication, Age Group, and Country)
    • U.S. 
      • By Care Model
    • Canada
      • By Care Model
  • Europe (By Care Model, Care Settings, Indication, Age Group, and Country/Sub-region)
    • Germany 
      • By Care Model
    • U.K.
      • By Care Model
    • France 
      • By Care Model
    • Spain 
      • By Care Model
    • Italy 
      • By Care Model
    • Scandinavia 
      • By Care Model
    • Rest of Europe
      • By Care Model
  • Asia Pacific (By Care Model, Care Settings, Indication, Age Group, and Country/Sub-region)
    • China 
      • By Care Model
    • Japan 
      • By Care Model
    • India 
      • By Care Model
    • Australia 
      • By Care Model
    • Southeast Asia 
      • By Care Model
    • Rest of Asia Pacific 
      • By Care Model
  • Latin America (By Care Model, Care Settings, Indication, Age Group, and Country/Sub-region)
    • Brazil
      • By Care Model
    • Mexico
      • By Care Model
    • Rest of Latin America
      • By Care Model
  • Middle East & Africa (By Care Model, Care Settings, Indication, Age Group, and Country/Sub-region)
    • GCC
      • By Care Model
    • South Africa
      • By Care Model
    • Rest of the Middle East & Africa
      • By Care Model

Research Methodology

1. Bottom-Up Approaches

Approach 1 -  Country-Level Hospice Utilization & Spending Analysis

  • Assess annual hospice admissions, patients served, patient-days, average daily census, and average length of stay across each country in scope.
  • Analyze hospice expenditure under government programs, public/private insurance, national health systems, managed care, self-pay, and service-linked charitable funding.
  • Separate formal hospice services from general palliative care, home healthcare, long-term nursing care, hospital care, and informal caregiving.
  • Evaluate utilization across routine hospice care, continuous/crisis care, general inpatient care, respite care, and other qualifying hospice services.
  • Estimate country market values using hospice patients × average length of stay × average provider revenue/reimbursement per patient-day.
  • Aggregate country estimates into regional and global totals and validate against provider revenues and national expenditure data.

Approach 2:   Eligible Patient Population, Hospice Penetration & Patient-Day Analysis

  • Assess annual deaths attributable to cancer, dementia, cardiovascular diseases, respiratory diseases, neurological disorders, organ failure, frailty, and other life-limiting conditions.
  • Estimate the population clinically eligible for hospice or specialist end-of-life care.
  • Apply country-specific hospice utilization/penetration rates to estimate patients receiving formal hospice care.
  • Estimate total hospice patient-days using admissions and average length of stay.
  • Split patient-days by care model, care setting, indication, and age group.
  • Apply country- and care-model-specific reimbursement/provider revenue per patient-day.
  • Cross-check patient volumes against national hospice statistics, provider census data, and reimbursement databases.

Approach 3:  Credible Secondary Sources & Institutional Data Cross-Check

  • Use CMS, NHS, CQC, MHLW, National Health Commission, MoHFW, AIHW, national health ministries, and other relevant regulatory/health authorities.
  • Use WHO, OECD, World Bank, Eurostat, national statistical agencies, mortality databases, and population projections.
  • Review hospice and palliative-care associations for utilization, access, workforce, and service-capacity indicators.
  • Track reimbursement revisions, hospice licensing, eligibility changes, facility expansion, acquisitions, partnerships, and provider consolidation.
  • Use company annual reports, SEC/regulatory filings, nonprofit disclosures, provider websites, earnings releases, and transaction announcements.
  • Exclude third-party syndicated market-research estimates as primary evidence for market sizing.

2. Top-Down Approaches

Approach 1:     Revenues and Market Share of Major Players (2021–2025)

  • Collect hospice-specific revenues from annual reports, SEC filings, nonprofit disclosures, earnings releases, acquisition documents, and official company sources.
  • Separate hospice revenues from home health, personal care, senior living, pharmacy, general palliative care, and other healthcare services.
  • Assess average daily census, annual admissions, patient-days, number of locations, inpatient capacity, geographic footprint, and payor mix.
  • Estimate in-scope revenues for private and nonprofit providers using patient-days, reimbursement rates, capacity, and operating footprint.
  • Calculate indicative provider market shares based only on hospice-attributable revenue.
  • Add a residual share for small, regional, charitable, public-sector, and independent hospice providers.

Approach 2:  Triangulation, Validation and Forecast Modeling

  • Compare estimates derived from:
  • Hospice provider revenues
  • Country-level hospice spending
  • Hospice admissions
  • Patient-days
  • Average length of stay
  • Hospice penetration
  • Revenue/reimbursement per patient-day
  • Provider capacity and locations
  • Inpatient hospice beds
  • Public/private payor expenditure
  • Eligible end-of-life patient population
  • Institutional and government data
  • Investigate and reconcile material differences between supply-side provider estimates and bottom-up patient/utilization estimates.
  • Remove revenues related to general palliative care, home healthcare, nursing-home accommodation, standalone pharmaceuticals, medical devices, and unrelated healthcare services.
  • Develop country and regional forecasts using:
  • Population ageing
  • Mortality and chronic-disease burden
  • Hospice penetration
  • Earlier referrals
  • Home-based hospice adoption
  • Provider capacity expansion
  • Reimbursement changes
  • Healthcare expenditure
  • Workforce availability
  • Telehospice adoption
  • Provider consolidation
  • Pricing/reimbursement inflation
  • Apply conservative, base-case, and higher-growth scenarios to check for overestimation and underestimation.
  • Finalize country-level values first and aggregate them into regional and global totals.

3. List of Key Sources

  • Annual reports
  • SEC and other regulatory filings
  • Nonprofit financial disclosures
  • Investor presentations
  • Earnings releases
  • Company/provider websites
  • CMS
  • Medicare Hospice Benefit databases
  • Medicare Payment Advisory Commission
  • NHS
  • Care Quality Commission
  • MHLW Japan
  • National Health Commission China
  • Ministry of Health & Family Welfare India
  • Australian Institute of Health and Welfare
  • WHO
  • OECD
  • World Bank
  • Eurostat
  • National statistical agencies
  • National mortality databases
  • National hospice and palliative-care associations
  • Government reimbursement databases
  • Hospice licensing databases
  • Provider-location directories
  • Acquisition and partnership announcements
  • Peer-reviewed hospice and palliative-care literature

4. Primary Interviews

Supply Side Interviews: 60%

  • Key respondents: Hospice care providers, standalone hospice operators, hospital-based hospice programs, home healthcare-based hospice providers, nonprofit and charitable hospice organizations, hospice administrators, clinical directors, medical directors, nursing directors, reimbursement specialists, finance executives, regional operating heads, strategy executives, commercial heads, and business-development executives.
  • Validate provider-level hospice revenues, annual admissions, average daily census, patient-days, average length of stay, revenue per patient-day, care-model mix, care-setting mix, payor mix, geographic presence, provider capacity, and competitive positioning.
  • Validate allocation of company revenues specifically to hospice care where diversified providers report broader home health, palliative care, personal care, senior living, or other healthcare-service revenues.
  • Assess expansion across routine hospice care, continuous or crisis care, general inpatient hospice care, respite care, home-based hospice programs, and other qualifying service models.
  • Validate reimbursement trends, provider capacity expansion, workforce availability, geographic expansion, acquisition activity, referral patterns, and anticipated changes in hospice service delivery.
  • Demand Side Interviews: 40%
  • Key Respondents: Physicians, hospice nurses, palliative-care specialists, hospital discharge planners, case managers, social workers, long-term care administrators, nursing-home operators, home-healthcare providers, payor representatives, healthcare-system administrators, caregivers, patient advocacy organizations, and community-care professionals.
  • Validate hospice referral volumes, patient eligibility, admission patterns, average length of stay, patient-day utilization, care-setting preferences, reimbursement coverage, and access to hospice services.
  • Assess demand across home-based hospice care, dedicated hospice facilities, hospitals, long-term care settings, and other qualifying care settings.


Frequently Asked Questions

According to Fortune Business Insights, the global market value stood at USD 44.38 billion in 2025 and is projected to reach USD 82.71 billion by 2034.

In 2025, the market value stood at USD 27.85 billion.

The market is expected to exhibit a CAGR of 7.3% during the forecast period.

By care model, the routine or standard hospice care segment is expected to lead the market.

The growing burden of chronic and terminal illness among an aging population to drive market growth.

Gentiva, VITAS Healthcare Corporation, Optum, Inc., Chapters Health System, Inc., and AccentCare, Inc. are the major players in the global market.

North America dominated the market in 2025.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 100
Download Free Sample

    man icon
    Mail icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann